Ionis Pharmaceuticals, Inc.
Compounds and Methods for the Modulation of Proteins

Last updated:

Abstract:

In certain embodiments, the present disclosure provides compounds and methods of increasing the amount or activity of a target protein in a cell. In certain embodiments, the compounds comprise a translation suppression element inhibitor. In certain embodiments, the translation suppression element inhibitor is a uORF inhibitor. In certain embodiments, the uORF inhibitor is an antisense compound.

Status:
Application
Type:

Utility

Filling date:

15 Sep 2020

Issue date:

2 Sep 2021